The CAPA That Was Really a Design Decision: Tracing Problems Back to Where They Start
Recurring CAPAs are often design decisions in disguise. MEDEVEX helps medical device teams learn how to trace them back to where they start, and fix them there.
Competitive Compliance: Why the New FDA QMSR Is an Opportunity, Not a Burden
Not sure where your quality system stands against the QMSR? MEDEVEX runs gap assessments and builds quality plans that close gaps on a defined timeline. Reach out for a conversation.
Five Mistakes That Turn an FDA Inspection Into a Warning Letter
Facing a 483, a Warning Letter, or just want to make sure you never see one? MEDEVEX has guided companies through remediation and back to competitive compliance. Let’s connect.